You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 8, August 24, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Antibody to Inner Ear Proteins in Patients With Progressive Hearing Loss

Correlation With Disease Activity and Response to Corticosteroid Treatment

Richard A. Moscicki, MD; José E. San Martin, MD; Carlos H. Quintero, MD; Steven D. Rauch, MD; Joseph B. Nadol, Jr, MD; Kurt J. Bloch, MD

JAMA. 1994;272(8):611-616.


Abstract

Objective.
—To test whether detection of serum antibody to a 68-kd inner ear protein distinguishes among different causes of sensorineural hearing loss, and identifies patients with active disease and those likely to respond to corticosteroid therapy.

Design.
—Serum samples were tested by Western blot using bovine inner ear extract as antigen, and results were correlated with patient information obtained by chart review.

Setting.
—Referral center.

Subjects of Study.
—Serum samples were obtained from patients with idiopathic, progressive, bilateral sensorineural hearing loss (IPBSNHL) (n=72) otosclerosis (n=11), Cogan's syndrome (n=8), patients with positive tests for antinuclear antibodies (n=10), and normal controls (n=53).

Main Outcome Measure.
—Detection of serum antibody to a 68-kd inner ear protein.

Results.
—Serum from 42 of 72 patients with IPBSNHL reacted with a 68-kd protein constituent of inner ear extract. This reactivity was not detected in serum from 11 of 11 patients with otosclerosis, or in eight of eight with Cogan's syndrome. It was found in serum from one of 10 patients with a positive test for antinuclear antibody and in one of 53 normal controls. Antibody to the 68-kd protein was detected in serum from 89% of patients with actively progressing IPBSNHL and none of the 25 patients with inactive disease (P<.001). Patients who were antibody-positive responded to steroid treatment more frequently than did those who were antibody-negative (P<.001).

Conclusions.
—These results indicate that the presence of circulating antibody to a 68-kd constituent of bovine inner ear extract serves as a marker for IPBSNHL and that its presence correlates with disease activity and responsiveness to corticosteroid treatment.

(JAMA. 1994;272:611-616)



Author Affiliations

From the Departments of Medicine (Drs Moscicki, San Martin, Quintero, and Bloch), and Otology and Laryngology (Drs Rauch and Nadol), Harvard Medical School; the Massachusetts Eye and Ear Infirmary (Drs Rauch and Nadol); and the Clinical Immunology and Allergy Units, General Medical Services, Massachusetts General Hospital (Drs Moscicki, San Martin, Quintero, and Bloch), Boston, Mass.


Footnotes

Presented in part at the 46th annual meeting of the American Academy of Allergy and Immunology, Baltimore, Md, March 24, 1990.

Reprint requests to the Clinical Immunology and Allergy Units, Massachusetts General Hospital, 32 Fruit St, Bulfinch 422, Boston, MA 02114-2696 (Dr Moscicki).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy
Sivakumar and Fife
Neurology 2005;65:1673-1674.
FULL TEXT  

Corticosteroid Response and Supporting Cell Antibody in Autoimmune Hearing Loss
Zeitoun et al.
Arch Otolaryngol Head Neck Surg 2005;131:665-672.
ABSTRACT | FULL TEXT  

Identification and Characterization of Choline Transporter-Like Protein 2, an Inner Ear Glycoprotein of 68 and 72 kDa That Is the Target of Antibody-Induced Hearing Loss
Nair et al.
J. Neurosci. 2004;24:1772-1779.
ABSTRACT | FULL TEXT  

Serologic Factors in Autoimmune Ear Disease
Bloch
JAMA 2004;291 :303-303.
FULL TEXT  

Different Distribution of HLA Class II Alleles According to Response to Corticosteroid Therapy in Sudden Sensorineural Hearing Loss
Yeo et al.
Arch Otolaryngol Head Neck Surg 2001;127:945-949.
ABSTRACT | FULL TEXT  

Frequency of Cochlear Enhancement on Magnetic Resonance Imaging in Patients With Autoimmune Sensorineural Hearing Loss
Zavod et al.
Arch Otolaryngol Head Neck Surg 2000;126:969-971.
ABSTRACT | FULL TEXT  

Deficiency of Naive T Cells in Patients With Sudden Deafness
Garcia-Berrocal et al.
Arch Otolaryngol Head Neck Surg 1997;123:712-717.
ABSTRACT  

Serum Antibodies to Heat Shock Protein 70 in Sensorineural Hearing Loss
Bloch et al.
Arch Otolaryngol Head Neck Surg 1995;121:1167-1171.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.